Acme United Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-6.6%projected annual EPS growth
Analyst Coverage
1analyst covering
FY Revenue (est.)
$226Mnext fiscal year
FY EPS (est.)
$2.64next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 20 Oct 2026 |
| Q4 2026 / Full Year 2026 Earnings Release | 25 Feb 2027 |
Monitoring Framework
Key Performance Indicators
Net Sales Growth Quarterly1,400.0%Target: 8% to 10% annual growth
Gross Margin Quarterly3,970.0%Target: 39% to 40%
Comparable Sales Growth (excluding My Medic) Quarterly600.0%Target: 6% to 7% historical organic growth
Watch Items
- Tariff-related costs and supply chain disruptionsTrigger: Gross margin compression below 38%Action: Accelerate strategic cost management, diversify international sourcing, and implement retail price adjustments.
- My Medic integration and SG&A expensesTrigger: SG&A expenses exceeding 36% of sales on a sustained basisAction: Leverage existing distribution networks, expand Amazon presence, and execute vertical integration to capture cost efficiencies.
- Interest coverage ratio and debt service dragTrigger: Interest coverage ratio falling below 3.0xAction: Prioritize free cash flow generation to pay down bank debt and optimize working capital.
Research as of 19 Jun 2026